Balyasny Asset Management LLC Bioventus Inc. Transaction History

Balyasny Asset Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$4.33 - $5.75 $143,807 - $190,969	-33,212 Reduced 38.22%	53,696 $279,000
Q4 2023 Feb 14, 2024	BUY	$2.89 - $5.34 $251,164 - $464,088	86,908 New	86,908 $458,000
Q2 2023 Aug 14, 2023	BUY	$0.93 - $3.64 $378,433 - $1.48 Million	406,918 New	406,918 $1.18 Million
Q4 2021 Feb 14, 2022	SELL	$12.37 - $16.77 $159,684 - $216,483	-12,909 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$13.7 - $17.25 $176,853 - $222,680	12,909 New	12,909 $183,000

141

45.8M

179K

124K

Ticker BVS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 61,664,200
Market Cap $658M
Description
Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral ner...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.